JAK2 and glioblastoma: Notably, exosomal circCMTM3 possessing growth factor-mimetic property non-classically activates the JAK2/STAT5A pathway promoting VM formation, which would be a potential vulnerability and orientation for GBM anti-vasculogenic therapies.